Background: Preeclampsia is characterized by increased lipid peroxidation and diminished antioxidant capacity; however, there is no consensus as to the extent of these conditions.
There is a complex interaction between free radicals and antioxidants, which modulates the generation of oxidative stress. Oxidative stress occurs when generation of reactive oxygen species (ROS) increases and overwhelms the body's antioxidant defenses. Free radicals are molecules with one or more unpaired electrons in the outer orbit (1) . These include hydroxyl radical, superoxide anion radical, and nitric oxide radical. On the other hand, ROS such as hydrogen peroxide and peroxynitrite do not have unpaired electrons.
Human cells have developed a wide range of antioxidant systems to limit production of ROS, inactivate them, and repair cell damage. ROS are a dual-edged sword-they are key messengers in maintaining physiological functions in the female reproductive tract, however, excessive and unrelenting ROS generation causes various pathologies. Pregnancy is characterized by increased generation of ROS. The generation of ROS is enhanced by increased placental mitochondrial activity (2) and the greatly increased placental production of the radical superoxide (3, 4) . This increase in the generation of superoxide is also reported to be associated with decreased levels of superoxide dismutase (3) , an antioxidant enzyme, in the placental trophoblast.
Preeclampsia is a complex multisystem disorder seen exclusively in the human species. Worldwide, it is a leading cause of maternal and fetal morbidity and mortality. Reduced perfusion as a result of abnormal placentation is thought to lead to ischemia reperfusion injury to the placenta. Placental oxidative stress, which results from the ischemia reperfusion injury, is increasingly reported to be involved in the etiopathogenesis of gestational hypertension/preeclampsia and associated with impaired glucose tolerance (5) . Placental oxidative stress has been proposed as a promoter of lipid peroxidation, and endothelial cell dysfunction associated with preeclampsia (6) (7) (8) (9) (10) . Lipid peroxidation has also been proposed to play an etiopathological role in various vascular complications of pregnancy, such as intrauterine growth restriction and gestational diabetes. However, this causal relationship between increased lipid peroxidation and preeclampsia is not universally supported. Some studies have reported that lipid peroxidation is not exacerbated in patients with preeclampsia (11) (12) (13) (14) .
Lipid peroxides are generated when free radicals interact with polyunsaturated fatty acids in the cell membrane and in plasma lipoproteins. This process can become self-perpetuating, leading to a cascade of lipid oxidation. The assessment of serum total thiobarbituric acid-reactive substances (TBARS) provides a measure of total serum lipid peroxidation, an indicator of whole-body free radical activity.
The increased lipid peroxidation leads to the consumption of antioxidants. This leads to reduction in levels of nonenzymatic antioxidants such as Vitamins A, C, and E, erythrocyte thiol, and glutathione as well as enzymatic antioxidants such as glutathione peroxidase and superoxide dismutase.
Research on oxidative stress in preeclampsia is mostly focused on studying the markers of oxidative stress locally in the placenta and systemically in the serum and plasma. A few studies have examined erythrocyte glutathione peroxidase levels. Most have been cross sectional or case-control studies comparing patients with preeclampsia to non-pre-eclamptic controls matched for age and gestational age.
There is a dearth of well-designed longitudinal studies investigating oxidative stress markers in preeclampsia. In this systematic review and metaanalysis, we aim to establish whether there is evidence to link lipid peroxidation and antioxidant status with preeclampsia.
METHODS

Identification of Studies
Studies were identified by performing an extensive search using BIOSIS, EMBASE, Medline, and the Cochrane database with the help of a professional librarian, as well as by hand-searching review articles and cross references (Fig. 1) . The search stretched from Unless otherwise noted below, each faculty's spouse/life partner (if any) has nothing to disclose.
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Lippincott (15) or ACOG (16) . These include a definition of preeclampsia as a blood pressure level of Ն140/90 mm Hg and, taken on 2 occasions 6 hours apart and 1ϩ proteinuria or greater.
Criteria for Selecting the Studies
Studies that were found to examine relevant parameters in preeclampsia cases compared to controls were evaluated on quality based on a scoring system devised by the authors (available from the authors on request). The methods, results, tables, and figures for each study were extracted. Two reviewers, blinded to the concluding data, authors, journal, and publication date of the articles evaluated each study on its methodological merits. A score was assigned to each study based on 4 overarching categories of bias: selection or follow-up bias, confounding bias, information or detection bias, and other sources of bias such as misclassification (17) . A higher score indicated less potential for bias. Studies that were deemed likely not to be biased despite deficiencies in reporting of methods, and those likely to be biased toward the null were included in the final meta-analysis (17) .
Data Extraction
The measures of interest for which data were extracted were all continuous and included MDA, lipid peroxides, lipid hydroperoxides, TBARS, isoprostanes, conjugated dienes, superoxide dismutase (SOD), catalase, glutathione transferase, glutathione peroxidase, and vitamins E and C in the appropriate fluids that included serum/plasma, erythrocytes, placenta, and urine. Population and study characteristics such as fasting or nonfasting samples (which may affect the MDA levels), selection of comparison group, and criteria for matching controls were extracted for potential further subgroup analyses.
Data Analysis
The data were analyzed by meta-analysis based on standardized mean differences (SMD) between cases and controls. The SMD of individual studies was determined by the mean difference between cases and controls weighted by the sample sizes of the study. Overall SMD and its 95% confidence interval (95% CI) were estimated for a study. A random effects model was used as the studies were from different patient populations and we are interested in extrapolating conclusions to populations beyond those in the studies. To investigate potential sources of heterogeneity, the I 2 statistic, which estimates the proportion of variability in the study due to heterogeneity rather than sampling error, was calculated. The I 2 statistic was calculated in the same manner as in the RevMan User Guide (version 4.2) (available at: www.cochrane.org). An I 2 of Ͻ30% indicates mild heterogeneity, whereas 30% to 50% and 50% to 100% reflect moderate heterogeneity and strong heterogeneity, respectively (18) . For each of the metaanalyses, when heterogeneity was high, individual studies that made large contributions to the heterogeneity were identified, and subgroup analysis was performed after excluding the relevant studies or by controlling for certain confounders such as age and gestational age. A P Ͻ 0.05 or SMD's within the 95% CI were considered significant in all statistical tests employed. The statistical software package R (available at: www.R-project.org) was used for all the analyses.
RESULTS
A search of the electronic databases yielded 1429 studies (Fig. 1 ). Hand searches of the bibliography did not yield any additional articles. Of these 1429, a total of 111 relevant articles were identified by examining the abstracts and titles. About 68 original articles contained data relevant to the analysis. After quality scoring, 26 studies were selected (Table 1) and 42 were excluded. Data were extracted from the selected 26 studies and grouped according to the different sources (such as plasma, serum, placenta, or decidual tissue) from which measurements were taken ( Table 2) . Oxidative stress markers and antioxidants, which were examined in less than 3 studies, are not presented. Thus, the oxidative stress markers that were assessed in this meta-analysis included MDA, TBARS and the antioxidants SOD, and Vitamins E and C. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia.
Mutlu-Türkoglu et al 31
Cross-sectional evaluation of preeclampsia cases and normotensive pregnancy controls.
Seventeen subjects diagnosed with preeclampsia were compared to 10 normotensive pregnant women.
TBARS, glutathione, GSH-Px, SOD, vitamin C.
TBARS levels were found to be significantly higher in preeclamptic cases than controls while the level of antioxidant activities was significantly decreased. Panburana et al 32 Cross-sectional evaluation of preeclampsia cases and normotensive pregnancy controls.
The control group was composed of 60 normotensive singleton pregnancies. Thirty cases of mild preeclampsia were also recruited.
Vitamins A, C, E, MDA. Preeclamptic women were found to have significantly lower levels of vitamin C in comparison to controls. However, there was no significant difference in vitamins A and E levels after adjusting for cholesterol. Paşaoglu et al 33
Patients were excluded as controls if they have previous history of hypertension, renal disease, or other metabolic disease.
MDA in plasma and erythrocytes.
Erythrocyte MDA was not significantly greater in cases than controls while plasma MDA was.
Raijmaker et al 34
Cross-sectional evaluation of pre-eclampsia cases and normotensive pregnancy controls.
Forty women with preeclampsia were recruited for this study. Two groups of controls were recruited.
TBARS.
TBARS was not found to be significantly different between cases and controls matched on gestational age. Twenty patients with mild preeclampsia were recruited to be evalu ated in comparison to 20 healthy uncomplicated pregnancies.
Conjugated dienes, MDA, vitamin E, GSH-Px.
Conjugated dienes were found to be significantly higher in cases compared to controls.
Var et al 38
A total of 20 patients with preeclampsia were recruited in conjunction with 20 normotensive controls matched on gestational age.
MDA.
MDA was significantly raised in preeclampsia patients in comparison to gestational age-matched controls.
Wu et al 39
Ten patients with preeclampsia were recruited for comparison with ten normotensive pregnant women.
Serum MDA. Serum MDA was significantly higher in patients with preeclampsia in comparison to controls.
Yanik et al 40
Eighteen preeclamptic patients and 25 normotensive controls were recruited for this study.
MDA, vitamin E. MDA was found to be significantly higher in cases while vitamin E was found to be significant lower.
Yoneyama et al 8
Twenty-six of preeclamptic women were recruited along with 26 normal controls.
MDA and ADA. Levels of plasma MDA and ADA were both significantly raised in preeclampsia patients in comparison to controls.
MDA indicates malondialdehyde; LPO, lipid peroxides; TBARS, thiobarbituric acid reactive substances; Iso P, isoprostanes; SOD, superoxide dismutase; GSH-PX, glutathione peroxidase; GSSG, oxidized glutathione; GSSG-R, glutathione reductase; AOP, antioxidant potential; Cp, ceruloplasmin; NO, nitric oxide; GSSG-R, glutathione reductase; GST, glutathione S-transferase; VEGF, vascular endothelial growth factor; sE-selectin, Soluble-E-selectin.
Malondialdehyde
MDA was measured in serum or plasma in 17 studies (cases ϭ 355, controls ϭ 390). In 7 of these studies, samples were taken after fasting. Gestational age and maternal age were matched in 6 of these 14 studies. Of these 6 studies, only 1 required the subjects to fast before serum samples were taken. The overall SMD in the 17 studies was an increase in MDA of 1.21 in cases compared to controls (95% CI: 0.76-1.66, Fig. 2) . However, the I 2 statistic that measures the degree of heterogeneity encountered in meta-analysis was found to be high at 88.9%. With the exclusion of 3 outlier studies (6, 12, 29) , the SMD changed slightly with SMD ϭ 0.94 (95% CI: 0.69-1.19) and the I 2 statistic changed from 89% to 59%, which is a common degree of heterogeneity encountered in meta-analysis. This SMD became 1.31 (95% CI: 0.68-1.93) when examining only studies with gestational age matched cases and controls and 1.68 (95% CI: 0.81-2.55) when examining studies including only fasting subjects.
Thiobarbituric Acid Reactive Substances
TBARS were examined in serum in 4 studies (cases ϭ 119, controls ϭ 106), (Fig. 3A) . Overall, the SMD for TBARS was 1.62 nmol/mL greater in cases than in controls (95% CI: 0.27-2.96). The I (Fig. 3B) . The significant TBAR difference remains even after subgroup analysis for heterogeneity adjustment according to the SMD values.
Superoxide Dismutase
SOD was measured in erythrocytes in 3 studies (cases ϭ 105, controls ϭ 108) (Fig. 4) . The overall estimate SMD estimate for SOD was Ϫ2.37 (95% CI: Ϫ4.76 to 0.03) with a trend toward being lower in cases than in controls. At 97%, the I 2 was indicative of high heterogeneity.
Isoprostane Derivatives
Of the 26 studies, 3 assessed different isoprostane derivatives. Regan et al measured urinary 8,12-isoiPF(2alpha)-VI, in a case-control study of severe preeclampsia (11), Barden et al measured free and total plasma as well as urinary 8-iso-prostane (20) . In another study in 2001, they measured total plasma total F 2 isoprostanes (21) . Because of these differences, the results could not be collated. In the 3 studies, these isoprostaglandin derivatives were found to be significantly raised in the respective compartment in cases compared to controls.
Vitamin E
Seven studies were included in the meta-analysis (cases ϭ 162, controls ϭ 225). The concentration of vitamin E was significantly less in serum or plasma of cases compared to controls (Fig. 5A) . The overall estimate of the difference based on SMD was 1.12 nmol/mL less in cases than controls (95% CI: Ϫ1.77 to Ϫ0.48). With the exclusion of Uotila (37) and Panburana (32) , the SMD changed slightly to Ϫ1.57 (95% CI: Ϫ2.05 to Ϫ1.09), while the I 2 decreased from 89.6% to 70.9% (Fig. 5B) .
Vitamin C
Three studies were evaluated Vitamin C (cases ϭ 71, controls ϭ 126). The SMD for Vitamin C was Ϫ0.53 (95% CI: Ϫ1.03 to Ϫ0.02) with I 2 ϭ 54.2%. (Fig. 6 ).
DISCUSSION
Our meta-analysis demonstrated a significant increase in serum MDA and TBARS levels in preeclamptic patients compared to those without preeclampsia. However, the conclusions about association, and the causality of that association in this meta-analysis, should be viewed with caution due to the limitations of studies in this review, differing study populations, different markers assessed, and various methodologies utilized to assess the markers (26, 27) . All the studies included were case-control studies and there can be an element of selection bias introduced because of confounding variables. It should also be noted that there may be element of publication bias as studies did not find an association between ROS markers and preeclampsia may not have been published.
There are various literature reports investigating the use of vitamin C and vitamin E supplementation to reduce oxidative stress, limit the injury of endothelial cells, and prevent or reduce disease severity of preeclampsia. Poston et al carried out a placebocontrolled trial in a diverse group of high-risk women, which demonstrated antioxidant supplementation was not associated with a reduction in the risk of preeclampsia; rather, it was associated with a significantly higher incidence of complications, including low birth weight, fetal academia, gestational hypertension, and the need for intravenous antihypertensive and magnesium sulfate therapies (41) . There were no significant differences in the primary or secondary outcomes between the vitamin group and placebo group. No differences were reported in the risks of preeclampsia, infant mortality/morbidity, or delivery of a low birth weight infant. In another RCT by Rumbold et al, the supplementation also was associated with increased risk of hospitalization due to hypertension in women and the use of antihypertensive therapy (42) . However, some of these trials were powered to detect only a higher risk reduction for preeclampsia and, the possibility of a smaller benefit of antioxidant therapy cannot be ruled out. Until such evidence is available the routine use of antioxidant vitamins by nulliparous, low-risk pregnant women or high-risk pregnant women to prevent preeclampsia or to improve perinatal morbidity is not supported even if causal relationship between oxidative stress and preeclampsia is established.
CONCLUSION
Overall, this meta-analysis emphasizes the biologic association of lipid peroxidation and preeclampsia. Deficiency of both enzymatic and nonenzymatic antioxidants is also observed in women with preeclampsia. However, future longitudinal studies estimating oxidative markers and antioxidants serially throughout pregnancy may be able to substantiate the association of elevated lipid peroxidation and diminished antioxidant levels with preeclampsia and the estimation of oxidative stress markers may be predictive of development of preeclampsia.
